
    
      After being informed about the study and potential risks, and providing written informed
      consent, a total of 40 patients will undergo vitreoretinal surgery with oral Triazolam and 40
      patients will undergo vitreoretinal surgery with intravenous sedation. The IV sedative will
      be determined by the anesthesiologist or certified registered nurse anesthetist but limited
      to midazolam, propofol, and fentanyl. The study will be a prospective, cross-sectional study
      with a 1:1 randomized procedure and unmasked.
    
  